Biosearch Seeks to Enter IVD Market with Expanded Roche License

Under the new license with Roche, Biosearch now has the right to manufacture and sell validated kits, including probes, primers, enzymes, and other essential nucleic acid amplification technologies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.